Oribalt Vilnius - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 27,023,534 | 25,920,432 | 21,614,463 | 19,963,993 | 24,131,802 | 26,725,655 | 23,992,821 | 25,215,082 |
| Profit before tax | 440,748 | 492,989 | 430,773 | 206,094 | 505,738 | 644,711 | 486,026 | 432,110 |
| Net profit | 320,365 | 410,022 | 344,269 | 151,778 | 420,533 | 535,253 | 404,359 | 348,648 |
| Equity | 2,581,143 | 2,991,165 | 3,335,434 | 3,487,212 | 3,907,745 | 4,042,998 | 3,447,357 | 3,546,005 |
| Liabilities | 11,364,863 | 9,291,077 | 7,558,658 | 6,513,619 | 7,448,444 | 9,994,209 | 9,425,443 | 11,112,123 |
| Non-current assets | 3,435,952 | 3,405,750 | 3,660,111 | 3,634,416 | 3,992,368 | 4,107,070 | 4,073,138 | 3,944,160 |
| Current assets | 10,591,584 | 9,008,549 | 7,238,438 | 6,395,847 | 7,373,864 | 9,939,549 | 8,799,337 | 10,735,049 |
| Total assets | 14,027,536 | 12,414,299 | 10,898,549 | 10,030,263 | 11,366,232 | 14,046,619 | 12,872,475 | 14,679,209 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 1,782,191 | 1,706,856 | 1,970,862 |
| Social insurance contributions | - | - | - | - | - | 367,280 | 395,906 | 419,482 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +9.4% | -4.1% | -16.6% | -7.6% | +20.9% | +10.7% | -10.2% | +5.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 2.3% | 3.3% | 3.2% | 1.5% | 3.7% | 3.8% | 3.1% | 2.4% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 12.4% | 13.7% | 10.3% | 4.4% | 10.8% | 13.2% | 11.7% | 9.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.2% | 1.6% | 1.6% | 0.8% | 1.7% | 2.0% | 1.7% | 1.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 1.6% | 1.9% | 2.0% | 1.0% | 2.1% | 2.4% | 2.0% | 1.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 4.4 | 3.1 | 2.3 | 1.9 | 1.9 | 2.5 | 2.7 | 3.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 523,881 | 545,693 | 447,196 | 413,048 | 446,885 | 476,535 | 423,402 | 456,382 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Oribalt Vilnius - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-02-18 | 2025-02-20 | 34310.40 |
| 2024-11-18 | 2024-11-27 | 0.40 |
Oribalt Vilnius - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Oribalt Vilnius, UAB (code 111472747) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €25.22M and net profit of €348.6K, with a profit margin of 1.4%. Revenue increased by 5.1% year on year, but remained 5.7% below the 2023 level, showing a decline from €26.73M in 2023 to €23.99M in 2024, followed by a partial recovery in 2025. Net profit followed a downward trend over the same period, moving from €535.3K in 2023 to €404.4K in 2024 and €348.6K in 2025. At the end of 2025, total assets stood at €14.68M, equity at €3.55M and liabilities at €11.11M. Key ratios indicate moderate profitability and leverage, with ROE at 9.8%, ROA at 2.4%, debt-to-equity at 3.13 and asset turnover at 1.72x. Revenue per employee was €458.5K, while profit per employee was €6.3K.